The new strategic Kyiv, Ukraine-based location comes after Corex experienced operational growth as a clinical trials logistics company in the country. The opening of this center, according to Corex, reinforces its commitment to the region’s growing clinical trial market.
“We are convinced that this latest addition to Corex international infrastructure will serve as a stepping stone to both strengthening the existing operations and opening new markets in the coming months,” said Rostislav Kachan, head of Corex Ukraine in a statement.
The logistics hub features temperature-controlled storage capabilities and walk-in refrigerators and has been inspected by the Ukrainian State Administration on Medicinal products.
Kachan said the company has “hit the ground running” and is already started managing existing clients at its new facility.
Expanding footprint in expanding region
In 2014, Synergy Research Group revealed that 108 of the 155 trials approved in Ukraine in the first half of 2014 were multinational, multi-center clinical trials. At the time, the contract research organizations (CROs) Quintiles (now Iqvia), PPD, and PSI AG conducted a majority of these trials.
Ukraine has an approximate population of 45m and follows EU directives and guidelines for clinical trial legislation and data quality. The company stated that clinical trial data from Ukraine is corroborated by both US Food and Drug Administration (FDA) and European Medicines Agency (EMA) inspections.